Download PDF
Semin Musculoskelet Radiol 2011; 15(3): 301-306
DOI: 10.1055/s-0031-1278428
© Thieme Medical Publishers

From Gaucher's Disease to Metabolic Radiology: Translational Radiological Research and Clinical Practice

Mario Maas1 , Marielle Kuijper1 , Erik M. Akkerman1
  • 1Department of Radiology, University of Amsterdam, Amsterdam, The Netherlands
Further Information

Publication History

Publication Date:
03 June 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Imaging has an increasing role in the management of patients with inborn errors of metabolism. This role is related to expensive enzyme replacement therapy that requires a surrogate biomarker, such as magnetic resonance imaging. This review paper raises the issue of the potential for metabolic radiology to become a subspecialty.

KEYWORDS

Metabolic radiology - Gaucher's disease - Morquio syndrome

REFERENCES

  • 1 Beutler E, Grabowski G A. Glucosylceramide liposes: Gaucher disease. In: Sciver C R, Beaudet A L, Sly W S, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases. New York, NY: McGraw-Hill; 1995: 2641-2670
    Google Scholar
  • 2 Rosenthal D I, Scott J A, Barranger J et al.. Evaluation of Gaucher disease using magnetic resonance imaging.  J Bone Joint Surg Am. 1986;  68 (6) 802-808
    PubMedGoogle Scholar
  • 3 Lanir A, Hadar H, Cohen I et al.. Gaucher disease: assessment with MR imaging.  Radiology. 1986;  161 (1) 239-244
    PubMedGoogle Scholar
  • 4 O'Keefe D, Rosenthal D I. Computed tomography and magnetic resonance imaging in Gaucher's disease. In: Bloem J L, Sartoris D J, eds. MRI and CT of the Musculoskeletal System: A Text-Atlas. Baltimore, MD: William & Wilkins; 1992: 130
    Google Scholar
  • 5 Rosenthal D I, Barton N W, McKusick K A et al.. Quantitative imaging of Gaucher disease.  Radiology. 1992;  185 (3) 841-845
    PubMedGoogle Scholar
  • 6 Vogler III J B, Murphy W A. Bone marrow imaging.  Radiology. 1988;  168 (3) 679-693
    PubMedGoogle Scholar
  • 7 Nyce J M, Steele J S, Gunderman R B. Bridging the knowledge divide in radiology education.  Radiology. 2006;  239 (3) 629-631
    CrossrefPubMedGoogle Scholar
  • 8 Dixon W T. Simple proton spectroscopic imaging.  Radiology. 1984;  153 (1) 189-194
    CrossrefPubMedGoogle Scholar
  • 9 Miller S P, Zirzow G C, Doppelt S H, Brady R O, Barton N W. Analysis of the lipids of normal and Gaucher bone marrow.  J Lab Clin Med. 1996;  127 (4) 353-358
    CrossrefPubMedGoogle Scholar
  • 10 Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease.  Blood Cells Mol Dis. 2001;  27 (6) 1005-1012
    CrossrefPubMedGoogle Scholar
  • 11 Johnson L A, Hoppel B E, Gerard E L et al.. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease.  Radiology. 1992;  182 (2) 451-455
    CrossrefPubMedGoogle Scholar
  • 12 Maas M, Akkerman E M, Venema H W, Stoker J, Den Heeten G J. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers.  J Comput Assist Tomogr. 2001;  25 (5) 691-697
    CrossrefPubMedGoogle Scholar
  • 13 Rosen B R, Fleming D M, Kushner D C et al.. Hematologic bone marrow disorders: quantitative chemical shift MR imaging.  Radiology. 1988;  169 (3) 799-804
    PubMedGoogle Scholar
  • 14 Akkerman E M, Maas M. A region-growing algorithm to simultaneously remove dephasing influences and separate fat and water in two-point Dixon imaging.  Paper presented at: Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology Meeting; 1995; Berkeley, California
    PubMedGoogle Scholar
  • 15 Maas M, Hollak C E, Akkerman E M, Aerts J F. Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience.  JBR-BTR. 2006;  89 (6) 318-321
    PubMedGoogle Scholar
  • 16 Maas M, Hollak C E, Akkerman E M, Aerts J M, Stoker J, Den Heeten G J. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter.  AJR Am J Roentgenol. 2002;  179 (4) 961-965
    PubMedGoogle Scholar
  • 17 Boomsma J M, van Dussen L, Wiersma M G et al.. Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study.  Blood Cells Mol Dis. 2010;  44 (3) 181-187
    CrossrefPubMedGoogle Scholar
  • 18 Cox T M, Aerts J M, Belmatoug N et al.. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.  J Inherit Metab Dis. 2008;  31 (3) 319-336
    CrossrefPubMedGoogle Scholar
  • 19 Vom Dahl S, Poll L, Di Rocco M et al.. Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients.  Curr Med Res Opin. 2006;  22 (6) 1045-1064
    CrossrefPubMedGoogle Scholar
  • 20 Aerts J M, van Breemen M J, Bussink A P et al.. Biomarkers for lysosomal storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease.  Acta Paediatr Suppl. 2008;  97 (457) 7-14
    CrossrefPubMedGoogle Scholar
  • 21 Maas M, Hangartner T, Mariani G et al.. Recommendations for the assessment and monitoring of skeletal manifestations in children with Gaucher disease.  Skeletal Radiol. 2008;  37 (3) 185-188
    CrossrefPubMedGoogle Scholar
  • 22 Vanhoenacker F M, Maas M. Guidelines for Belgian MR centers for monitoring of bone marrow involvement in patients with Gaucher disease.  JBR-BTR. 2006;  89 (6) 321-324
    PubMedGoogle Scholar
  • 23 Poll L W, Cox M L, Godehardt E, Steinhof V, vom Dahl S. Whole body MRI in type I Gaucher patients: evaluation of skeletal involvement.  Blood Cells Mol Dis. 2011;  46 (1) 53-59
    CrossrefPubMedGoogle Scholar
  • 24 Robertson P L, Maas M, Goldblatt J. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.  AJR Am J Roentgenol. 2007;  188 (6) 1521-1528
    CrossrefPubMedGoogle Scholar
  • 25 Maas M, van Kuijk C, Stoker J et al.. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging—initial experience.  Radiology. 2003;  229 (2) 554-561
    CrossrefPubMedGoogle Scholar
  • 26 de Fost M, Hollak C E, Groener J E et al.. Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.  Blood. 2006;  108 (3) 830-835
    CrossrefPubMedGoogle Scholar
  • 27 DeMayo R F, Haims A H, McRae M C, Yang R, Mistry P K. Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease.  AJR Am J Roentgenol. 2008;  191 (1) 115-123
    CrossrefPubMedGoogle Scholar
  • 28 SPHINX Amsterdam Lysosome Center. Mission statement. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.nl/index.cfm?pid=8626 Accessed February 4, 2011
    Google Scholar
  • 29 SPHINX Amsterdam Lysosome Center. Education program. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.nl/index.cfm?pid=9327 Accessed January 16, 2011
    Google Scholar
  • 30 Garrod A. The incidence of alkaptonuria: a study in chemical individuality.  Lancet. 1902;  2 1616-1620
    PubMedGoogle Scholar
  • 31 C.E.M. Hollak: Who is who in research: AMC. University of Amsterdam Academic Medical Center (AMC) Web site. Available at: http://www.amc.uva.nl/?pid=6454&rm=person&medewerkerid=446 Accessed February 6, 2011
    Google Scholar
  • 32 Professor Carla Hollak receives the sixth Alan Gordon Memorial Award. Gauchers Association Web site. Available at: http://www.gaucher.org.uk/enews.php?id=326 Accessed January 12, 2011
    Google Scholar
  • 33 Hendriksz C J. Inborn errors of metabolism for the diagnostic radiologist.  Pediatr Radiol. 2009;  39 (3) 211-220
    PubMedGoogle Scholar
  • 34 Northover H, Cowie R A, Wraith J E. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review.  J Inherit Metab Dis. 1996;  19 (3) 357-365
    CrossrefPubMedGoogle Scholar
  • 35 Dvorak-Ewell M, Wendt D, Hague C et al.. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.  PLoS ONE. 2010;  5 (8) e12194
    CrossrefPubMedGoogle Scholar
  • 36 Bashir A, Gray M L, Hartke J, Burstein D. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI.  Magn Reson Med. 1999;  41 (5) 857-865
    CrossrefPubMedGoogle Scholar
  • 37 Burstein D, Gray M, Mosher T, Dardzinski B. Measures of molecular composition and structure in osteoarthritis.  Radiol Clin North Am. 2009;  47 (4) 675-686
    CrossrefPubMedGoogle Scholar
  • 38 Gray M L, Burstein D, Kim Y J, Maroudas A. 2007 Elizabeth Winston Lanier Award Winner. Magnetic resonance imaging of cartilage glycosaminoglycan: basic principles, imaging technique, and clinical applications.  J Orthop Res. 2008;  26 (3) 281-291
    CrossrefPubMedGoogle Scholar
  • 39 Lohmander L S. Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.  J Anat. 1994;  184 (Pt 3) 477-492
    PubMedGoogle Scholar
  • 40 Keshari K R, Lotz J C, Kurhanewicz J, Majumdar S. Correlation of HR-MAS spectroscopy derived metabolite concentrations with collagen and proteoglycan levels and Thompson grade in the degenerative disc.  Spine (Phila Pa 1976). 2005;  30 (23) 2683-2688
    CrossrefPubMedGoogle Scholar
  • 41 Zuo J, Saadat E, Romero A et al.. Assessment of intervertebral disc degeneration with magnetic resonance single-voxel spectroscopy.  Magn Reson Med. 2009;  62 (5) 1140-1146
    CrossrefPubMedGoogle Scholar
  • 42 Urban J P, McMullin J F. Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration.  Spine (Phila Pa 1976). 1988;  13 (2) 179-187
    CrossrefPubMedGoogle Scholar
  • 43 Antoniou J, Steffen T, Nelson F et al.. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.  J Clin Invest. 1996;  98 (4) 996-1003
    CrossrefPubMedGoogle Scholar

Mario MaasM.D. Ph.D. 

Department of Radiology, University of Amsterdam, Academic Medical Center

Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

Email: m.maas@amc.uva.nl

      >